Jarmalavičiūtė Akvilė, Tunaitis Virginijus, Pivoraitė Ugnė, Venalis Algirdas, Pivoriūnas Augustas
Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania; Department of Neurobiology and Biophysics, Faculty of Natural Sciences, Vilnius University, Vilnius, Lithuania.
Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Cytotherapy. 2015 Jul;17(7):932-9. doi: 10.1016/j.jcyt.2014.07.013. Epub 2015 May 13.
Stem cells derived from the dental pulp of human exfoliated deciduous teeth (SHEDs) have unique neurogenic properties that could be potentially exploited for therapeutic use. The importance of paracrine SHED signaling for neuro-regeneration has been recognized, but the exact mechanisms behind these effects are presently unknown. In the present study, we investigated the neuro-protective potential of exosomes and micro-vesicles derived from SHEDs on human dopaminergic neurons during oxidative stress-induced by 6-hydroxy-dopamine (6-OHDA).
ReNcell VM human neural stem cells were differentiated into dopaminergic neurons and treated with 100 μmol/L of 6-OHDA alone or in combination with exosomes or micro-vesicles purified by ultracentrifugation from SHEDs cultivated in serum-free medium under two conditions: in standard two-dimensional culture flasks or on laminin-coated micro-carriers in a bioreactor. Real-time monitoring of apoptosis was performed with the use of time-lapse confocal microscopy and the CellEvent Caspase-3/7 green detection reagent.
Exosomes but not micro-vesicles derived from SHEDs grown on the laminin-coated three-dimensional alginate micro-carriers suppressed 6-OHDA-induced apoptosis in dopaminergic neurons by approximately 80% throughout the culture period. Strikingly, no such effects were observed for the exosomes derived from SHEDs grown under standard culture conditions.
Our results suggest that exosomes derived from SHEDs are considered as new potential therapeutic tool in the treatment of Parkinson's disease.
源自人脱落乳牙牙髓的干细胞(SHEDs)具有独特的神经源性特性,可潜在地用于治疗用途。旁分泌SHED信号对神经再生的重要性已得到认可,但这些作用背后的确切机制目前尚不清楚。在本研究中,我们研究了在6-羟基多巴胺(6-OHDA)诱导的氧化应激期间,源自SHEDs的外泌体和微泡对人多巴胺能神经元的神经保护潜力。
将ReNcell VM人神经干细胞分化为多巴胺能神经元,并在两种条件下单独用100μmol/L的6-OHDA处理,或与通过超速离心从无血清培养基中培养的SHEDs中纯化的外泌体或微泡联合处理:在标准二维培养瓶中或在生物反应器中涂有层粘连蛋白的微载体上。使用延时共聚焦显微镜和CellEvent Caspase-3/7绿色检测试剂对细胞凋亡进行实时监测。
在整个培养期间,源自生长在涂有层粘连蛋白的三维藻酸盐微载体上的SHEDs的外泌体而非微泡抑制了多巴胺能神经元中6-OHDA诱导的细胞凋亡约80%。令人惊讶的是,对于在标准培养条件下生长的SHEDs衍生的外泌体未观察到此类作用。
我们的结果表明,源自SHEDs的外泌体被认为是治疗帕金森病的新的潜在治疗工具。